ICMR licensed three indigenous biomedical technologies to Emcure and Biological E, advancing an HPV precancer therapy and vaccines for typhoid, paratyphoid and Shigella toward affordable commercial ...
A stepwise HIV vaccine strategy has induced broadly neutralizing antibodies in primates, hinting that a truly protective HIV ...
India has approved QDENGA, its first dengue vaccine. A pulmonary specialist explains who should get vaccinated, who should ...
The Central Drugs Standard Control Organisation (CDSCO) has granted marketing authorisation for India's first dengue vaccine, ...
Qdenga, cleared this week for ages 4 to 60, is one of only a few dengue vaccines in the world. It is to be injected in two ...
Scientists have taken a major step toward developing an effective HIV vaccine after a new experimental vaccine successfully ...
ICMR has licensed a cervical cancer drug candidate to Emcure and two vaccine technologies to Biological E to accelerate ...
Experimental KRAS Vaccine Generates Immune Response Against Pancreatic Cancer in People at High Risk
Researchers at the Johns Hopkins Kimmel Cancer Center and its Skip Viragh Center for Pancreatic Cancer report that an ...
Vietnam Investment Review on MSN
Takeda's dengue vaccine wins India's first approval
NEW DELHI, July 21, 2026 /PRNewswire/ -- Takeda today announced that India's Drug Controller General of India (DCGI) has granted marketing authorization for Takeda's dengue vaccine (TAK-003) for the ...
Serum Institute of India has partnered with Gates Medical Research Institute to manufacture M72/AS01E, a tuberculosis vaccine ...
Vietnam and France have strengthened cooperation on next-generation vaccine technology as VNVC and Sanofi advance plans to ...
A new HIV vaccine has generated powerful broadly neutralizing antibodies in animal studies and has now entered human trials, ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results